Literature DB >> 3627952

Effects of the antisecretory factor in pigs.

S Lange, I Lönnroth, E Skadhauge.   

Abstract

The effect of the antisecretory factor (ASF) on experimental porcine enterotoxin-induced jejunal secretion was tested. The heat-labile enterotoxin (LT) from Escherichia coli and cholera toxin (CT) was used for challenge in ligated intestinal loops. Less than 10 units of ASF inhibited the LT-induced secretion, while that due to CT required more than 10 units of ASF. ASF was effective only when administered prior to toxin challenge, and could be given either intravenously or intra-intestinally. Mixing of ASF with specific anti-ASF antibodies prior to injection abolished its antisecretory effect. LT- and CT-induced secreted fluid contained equal concentrations of Na+, K+ and Cl-, and the ionic concentration was not affected by ASF. Less than 0.1 units of ASF per pituitary gland was present in 3- and 5-week old pigs, while it increased to 4.5 units in 28-week old animals, and to 12.2 units in pigs older than two years. However, after intra-intestinal vaccination with 2.0 mg CT, the pituitary ASF content in the 5-week old animals increased to 2.0 units within 24 h.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3627952     DOI: 10.1007/BF00583485

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  13 in total

1.  Human diarrheal disease caused by enterotoxigenic Escherichia coli.

Authors:  R B Sack
Journal:  Annu Rev Microbiol       Date:  1975       Impact factor: 15.500

Review 2.  Neurobiology of the intestinal mucosa.

Authors:  H J Cooke
Journal:  Gastroenterology       Date:  1986-04       Impact factor: 22.682

Review 3.  Cholera and other enterotoxin-related diarrheal diseases.

Authors:  C C Carpenter
Journal:  J Infect Dis       Date:  1972-11       Impact factor: 5.226

4.  A hormone-like protein from the pituitary gland inhibits intestinal hypersecretion induced by cholera toxin.

Authors:  I Lönnroth; S Lange
Journal:  Regul Pept Suppl       Date:  1985

5.  An inhibitory protein of intestinal fluid secretion reverses neuronal GABA transport.

Authors:  S Lange; I Lönnroth; A Palm; H Hydén
Journal:  Biochem Biophys Res Commun       Date:  1985-08-15       Impact factor: 3.575

Review 6.  Cyclic nucleotides and their role in gastrointestinal secretion.

Authors:  D V Kimbert
Journal:  Gastroenterology       Date:  1974-11       Impact factor: 22.682

7.  Bile and milk from cholera toxin treated rats contain a hormone-like factor which inhibits diarrhea induced by the toxin.

Authors:  S Lange; I Lönnroth
Journal:  Int Arch Allergy Appl Immunol       Date:  1986

8.  Glucose-stimulated fluid absorption in the pig small intestine during the early stage of swine dysentery.

Authors:  R A Argenzio
Journal:  Am J Vet Res       Date:  1980-12       Impact factor: 1.156

9.  Mechanism of toxin secretion by Vibrio cholerae investigated in strains harboring plasmids that encode heat-labile enterotoxins of Escherichia coli.

Authors:  T R Hirst; J Sanchez; J B Kaper; S J Hardy; J Holmgren
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 11.205

10.  Intestinal adaptation to cyclic AMP-mediated hypersecretion induced by the heat-labile enterotoxin of Vibrio cholerae and Escherichia coli.

Authors:  I Lönnroth; H A Hansson; S Lange
Journal:  Acta Pathol Microbiol Immunol Scand B       Date:  1984-02
View more
  10 in total

1.  Effect of antisecretory factor on Escherichia coli STa enterotoxin-induced alkalinisation of pig jejunal acid microclimate.

Authors:  G T McEwan; B Schousboe; E Skadhauge
Journal:  Pflugers Arch       Date:  1990-10       Impact factor: 3.657

2.  Antisecretory factor peptide AF-16 inhibits the secreted autotransporter toxin-stimulated transcellular and paracellular passages of fluid in cultured human enterocyte-like cells.

Authors:  Valérie Nicolas; Vanessa Liévin-Le Moal
Journal:  Infect Immun       Date:  2014-12-22       Impact factor: 3.441

3.  Food induced stimulation of the antisecretory factor can improve symptoms in human inflammatory bowel disease: a study of a concept.

Authors:  S Björck; I Bosaeus; E Ek; E Jennische; I Lönnroth; E Johansson; S Lange
Journal:  Gut       Date:  2000-06       Impact factor: 23.059

4.  Age and segmental differences in 5-hydroxytryptamine-induced hypersecretion in the pig small intestine.

Authors:  M L Grøndahl; M B Hansen; I E Larsen; E Skadhauge
Journal:  J Comp Physiol B       Date:  1996       Impact factor: 2.200

5.  Antisecretory Factor-Mediated Inhibition of Cell Volume Dynamics Produces Antitumor Activity in Glioblastoma.

Authors:  Shirin Ilkhanizadeh; Hanna Sabelström; Yekaterina A Miroshnikova; Aaron Frantz; Wen Zhu; Aurora Idilli; Jon N Lakins; Christin Schmidt; David A Quigley; Trenten Fenster; Edith Yuan; Jacqueline R Trzeciak; Supna Saxena; Olle R Lindberg; Janna K Mouw; Jason A Burdick; Sergey Magnitsky; Mitchel S Berger; Joanna J Phillips; Daniele Arosio; Dandan Sun; Valerie M Weaver; William A Weiss; Anders I Persson
Journal:  Mol Cancer Res       Date:  2018-02-05       Impact factor: 5.852

6.  Food-induced stimulation of the antisecretory factor to improve symptoms in Meniere's disease: our results.

Authors:  Alfonso Scarpa; Massimo Ralli; Pasquale Viola; Claudia Cassandro; Matteo Alicandri-Ciufelli; Maurizio Iengo; Giuseppe Chiarella; Marco de Vincentiis; Michele Cavaliere; Ettore Cassandro
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-10-11       Impact factor: 2.503

7.  Antisecretory factor suppresses intestinal inflammation and hypersecretion.

Authors:  E Johansson; E Jennische; S Lange; I Lönnroth
Journal:  Gut       Date:  1997-11       Impact factor: 23.059

8.  Effects of anti-secretory factor (ASF) on irritable bowel syndrome (IBS). A double-blind, randomized study.

Authors:  Rickard Ekesbo; Peter M Nilsson; Kristina Sjölund
Journal:  Scand J Prim Health Care       Date:  2008       Impact factor: 2.581

9.  The effect of antisecretory factor on the permeability of nerve cell membrane to chloride ion.

Authors:  S Lange; I Lönnroth; A Palm; H Hydén
Journal:  Pflugers Arch       Date:  1987-12       Impact factor: 3.657

10.  Salovum egg yolk containing antisecretory factor as an adjunct therapy in severe cholera in adult males: a pilot study.

Authors:  Nur H Alam; Hasan Ashraf; Maryam Olesen; Mohammed A Salam; Niklaus Gyr; Remy Meier
Journal:  J Health Popul Nutr       Date:  2011-08       Impact factor: 2.000

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.